Invo Bioscience Inc (INVO)

$0.83 -0.03 (-2.91%)
Market Cap 3.17M
Revenue (ttm) 3.02M
Net Income (ttm) -8.03M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 125,200
Avg Vol 1,316,252
Day's Range N/A - N/A
Shares Out 3.81M
Stochastic %K 26%
Beta 1.43
Analysts Hold
Price Target $2.00
bruceleeboy
bruceleeboy May. 10 at 2:08 PM
$IMNPQ.DL0922 $IVF $INVO Immunai & AstraZeneca…
3 · Reply
bruceleeboy
bruceleeboy May. 10 at 2:06 PM
$IMNPQ.DL0922 $IVF $INVO More on Naya 211…
0 · Reply
bruceleeboy
bruceleeboy May. 10 at 2:05 PM
$IMNPQ.DL0922 $IVF $INVO Naya hire… Laurent Navarro
0 · Reply
bruceleeboy
bruceleeboy May. 8 at 3:11 AM
$INVO I believe we do get AstraZeneca shares and/or comparable or greater value. Managements actions/ activities, overall deal timeline to date, gross and apparently selfish disregard during execution, persistent misdirection, bankruptcy & Alexion acquisition timing, citation of this being the ‘Golden ticket’, multiple discrete Spac fundings and a host of other things that have transpired don’t speak to a small deal… rather a deal that’s accumulated value deliberately under the radar for well over a decade. I believe Bertilimumab was the catalyst and overall binding agent. They didn’t do this for $20 or $50. They did it for AZ value which has consolidated and aligned over the past 6 months… or potentially something of equivalent or GREATER value. Maybe our expectations are low with AstraZeneca.
2 · Reply
PennyScam
PennyScam May. 8 at 12:57 AM
$INVO RK. You know. I’ve looking over everything again. I don’t see Alexion taking everything. I’m thinking they got fire sale of a deal and their money was then used to support the BK. That’s how I see it. Ceplene is still gone with the wind and being pushed by that Delbert Labratories who took over the rights from Noventia. So who knows what’s happening there. I’m starting to actually think I got seriously fucked here and I we may just end up with shares in a couple small companies at best. I think the tax free saving played a massive role in the sale. I’m no finance guy here but that’s what I believe. I no longer believe I am getting shares in Astra Zeneca. Of course no one ever knows the details but I believe this isn’t as big as I assumed. I don’t know if it was you who believed or Bruce but sorry for the news. If you see something, let me know. I think there is still lots of great spin offs to come and maybe even some more share exchanges but that’s about it. Stay tuned. CK
1 · Reply
PennyScam
PennyScam May. 7 at 1:35 PM
$INVO I wonder when Cellectis comes back into the fold. I would prefer keeping things separate. Ck
1 · Reply
PennyScam
PennyScam May. 6 at 12:42 PM
$INVO We are always last for funding. I hate being last. It sucks. I like the way this company roles. Nice….https://ir.telixpharma.com/static-files/34c01b28-0377-4387-9397-c8ac422f3d78
0 · Reply
PennyScam
PennyScam May. 5 at 10:37 PM
$INVO Bruce, at the end of the day, I still believe that I am getting my Astra shares. Which is crazy if true. I take complete ownership of that belief. It might be hard for some to believe but its happening. lol. At least I believe it is. Lol. What do I know. I don’t know if I believe Naya / Cytovia being in play with Astra. At least not yet. We still need Ceplene recognized. Same goes for Amiket. I think ESHA is coming in to help finance runway for Naya deal. I am still also not leaving my belief that ICO or Satellos will come back in the picture sooner than later. Who knows. Crazy K
2 · Reply
PennyScam
PennyScam May. 2 at 3:59 PM
$INVO This company is also well into it. https://alpha-fusion.com/en/ Looks like the race has been on for a bit. We’ll see where this Naya partnership goes with Atley. Or shall I say possibly Cytovia’s relationship. Who knows. Ck
0 · Reply
PennyScam
PennyScam May. 2 at 3:43 PM
$INVO RK. Do you know much about these Cyclotron machines? The cost per unit is from 15 - 60 million pending on the size and output. Big bucks. That’s a pretty crazy device. A lot of universities use them for research. I’ve never even heard of this thing. It uses a magnet field to bend charged particles / protons blah blah blah. It’s interesting stuff. I’m trying to learn this crap. It’s a challenge for this old brain. I can’t even remember dates and here I am trying to learn about isotope production and proton therapy and now radio stuff. This is like learning a new language. I’m pretty pumped about STC Biologics and the development of NanomAbs. Targeted delivery👍🏻. I hope Benita has some good news soon. Plenty to look forward to. I am excited about AST. It’s a little nerve wrecking with this new mind boggling science. I know no one that shares my interest other than the Bozos in this room. I love pioneering with great minds. Always learning sharpening my pencil. Be well. CK
0 · Reply
Latest News on INVO
No data available.
bruceleeboy
bruceleeboy May. 10 at 2:08 PM
$IMNPQ.DL0922 $IVF $INVO Immunai & AstraZeneca…
3 · Reply
bruceleeboy
bruceleeboy May. 10 at 2:06 PM
$IMNPQ.DL0922 $IVF $INVO More on Naya 211…
0 · Reply
bruceleeboy
bruceleeboy May. 10 at 2:05 PM
$IMNPQ.DL0922 $IVF $INVO Naya hire… Laurent Navarro
0 · Reply
bruceleeboy
bruceleeboy May. 8 at 3:11 AM
$INVO I believe we do get AstraZeneca shares and/or comparable or greater value. Managements actions/ activities, overall deal timeline to date, gross and apparently selfish disregard during execution, persistent misdirection, bankruptcy & Alexion acquisition timing, citation of this being the ‘Golden ticket’, multiple discrete Spac fundings and a host of other things that have transpired don’t speak to a small deal… rather a deal that’s accumulated value deliberately under the radar for well over a decade. I believe Bertilimumab was the catalyst and overall binding agent. They didn’t do this for $20 or $50. They did it for AZ value which has consolidated and aligned over the past 6 months… or potentially something of equivalent or GREATER value. Maybe our expectations are low with AstraZeneca.
2 · Reply
PennyScam
PennyScam May. 8 at 12:57 AM
$INVO RK. You know. I’ve looking over everything again. I don’t see Alexion taking everything. I’m thinking they got fire sale of a deal and their money was then used to support the BK. That’s how I see it. Ceplene is still gone with the wind and being pushed by that Delbert Labratories who took over the rights from Noventia. So who knows what’s happening there. I’m starting to actually think I got seriously fucked here and I we may just end up with shares in a couple small companies at best. I think the tax free saving played a massive role in the sale. I’m no finance guy here but that’s what I believe. I no longer believe I am getting shares in Astra Zeneca. Of course no one ever knows the details but I believe this isn’t as big as I assumed. I don’t know if it was you who believed or Bruce but sorry for the news. If you see something, let me know. I think there is still lots of great spin offs to come and maybe even some more share exchanges but that’s about it. Stay tuned. CK
1 · Reply
PennyScam
PennyScam May. 7 at 1:35 PM
$INVO I wonder when Cellectis comes back into the fold. I would prefer keeping things separate. Ck
1 · Reply
PennyScam
PennyScam May. 6 at 12:42 PM
$INVO We are always last for funding. I hate being last. It sucks. I like the way this company roles. Nice….https://ir.telixpharma.com/static-files/34c01b28-0377-4387-9397-c8ac422f3d78
0 · Reply
PennyScam
PennyScam May. 5 at 10:37 PM
$INVO Bruce, at the end of the day, I still believe that I am getting my Astra shares. Which is crazy if true. I take complete ownership of that belief. It might be hard for some to believe but its happening. lol. At least I believe it is. Lol. What do I know. I don’t know if I believe Naya / Cytovia being in play with Astra. At least not yet. We still need Ceplene recognized. Same goes for Amiket. I think ESHA is coming in to help finance runway for Naya deal. I am still also not leaving my belief that ICO or Satellos will come back in the picture sooner than later. Who knows. Crazy K
2 · Reply
PennyScam
PennyScam May. 2 at 3:59 PM
$INVO This company is also well into it. https://alpha-fusion.com/en/ Looks like the race has been on for a bit. We’ll see where this Naya partnership goes with Atley. Or shall I say possibly Cytovia’s relationship. Who knows. Ck
0 · Reply
PennyScam
PennyScam May. 2 at 3:43 PM
$INVO RK. Do you know much about these Cyclotron machines? The cost per unit is from 15 - 60 million pending on the size and output. Big bucks. That’s a pretty crazy device. A lot of universities use them for research. I’ve never even heard of this thing. It uses a magnet field to bend charged particles / protons blah blah blah. It’s interesting stuff. I’m trying to learn this crap. It’s a challenge for this old brain. I can’t even remember dates and here I am trying to learn about isotope production and proton therapy and now radio stuff. This is like learning a new language. I’m pretty pumped about STC Biologics and the development of NanomAbs. Targeted delivery👍🏻. I hope Benita has some good news soon. Plenty to look forward to. I am excited about AST. It’s a little nerve wrecking with this new mind boggling science. I know no one that shares my interest other than the Bozos in this room. I love pioneering with great minds. Always learning sharpening my pencil. Be well. CK
0 · Reply
PennyScam
PennyScam May. 2 at 12:20 AM
$INVO sorry I meant Immune has until end of month. Hilarious. ESHA can fuck off. So can Shum. Still hoping for Alexion to do something. Crazy K
0 · Reply
PennyScam
PennyScam May. 1 at 10:39 PM
$INVO Bruce, nothing is coming until Fall. The shit will hit the fan on the date that Teper leaves or doesn’t leave. All I know is that nothing good happens in August. So the fact that they are running this to then only means one thing. I see them delaying this all. I see distributions rolled out in a fucking snail pace fashion. Enjoy your summer. I see no liquidity until October or later. Crazy K
1 · Reply
PennyScam
PennyScam May. 1 at 9:48 PM
$INVO I guess ESHA has until end of May. Who knows we’ll see. What a beautiful day people. Hope everyone is enjoying themselves today. Best to you. Crazy K
0 · Reply
PennyScam
PennyScam Apr. 23 at 2:02 PM
$INVO RK. Ceplene still very active.
0 · Reply
PennyScam
PennyScam Apr. 23 at 1:06 PM
$INVO I predict this Naya company’s stock will be worth a penny in a couple years. It’s going to be crazy RK. I hope you are prepared mentally. Eventually the big SUCK will be turned on after market regulates next year. The petrol dollar suck has already begun. Inflation will be coming. Then comes people selling. Then comes people entering savings cause wages will fall behind. Can’t wait to see the great deals coming to me in two plus years. The only sad thing is that people won’t be too happy. lol. Who cares. Know one. lol. Louis had it right…..What a wonderful world……CK
0 · Reply
PennyScam
PennyScam Apr. 23 at 12:45 PM
$INVO RK. You know what I think of this media. It means jack shit. It just shows that he has the funding to carry on til exit. They will most likely do something in June / July and then fuck off for the year. So potential valuation build in Summer and then scaling in Fall to then exit next Spring / Summer. Thats cutting things close. I see market remaining good for 6-12 months and then ABSOLUTE HELL. lol. Ck
0 · Reply
rlkloehn
rlkloehn Apr. 22 at 9:49 PM
$INVO new video out https://youtu.be/XCtt3CedDA8?si=uep8qBOBJ_GdLUDv
2 · Reply
PennyScam
PennyScam Apr. 19 at 1:59 PM
$INVO I think they have updated now. So they were in the dog house for a bit. I never saw that. I’m glad they updated it all. Fines aren’t fun. I don’t mind them. As our AZN leader says, you can’t take risks at 30,000 feet up in the air. Eventually you have to expose yourself. We should see us in Phase 3 clinicals this year. I’m excited. Must see this to the end. Ck
0 · Reply
PennyScam
PennyScam Apr. 19 at 1:48 PM
$INVO Naughty Alexion. Smarten up. Ck
1 · Reply
PennyScam
PennyScam Apr. 19 at 1:46 PM
$INVO Thanks for the info people on internet. You are always thinking of me. I appreciate you and your help. It looks like certain folk are being naughty. Crazy K https://www.fda.gov/media/189981/download#:~:text=Pharmacodynamic%20Effect%20of%20Bertilimumab%20in%20Patients%20With%20Newly%20Diagnosed%2C%20Moderate%20to.
0 · Reply
PennyScam
PennyScam Apr. 18 at 11:42 PM
$INVO RK. It just clicked they don’t have to file tax return until next year. So they have the whole year to fart around. Just looked and Final Decree, case closed was in January of this year. Now that is some sneaky bullshit. So one more reason for them to not distribute.
0 · Reply
PennyScam
PennyScam Apr. 13 at 10:53 PM
$INVO So where did this go. Maybe they terminated program. Don’t see it….. “NY-500, with its tetravalent bifunctional design, targets PD-1, a critical immune checkpoint, and VEGF, which influences angiogenesis. This dual-targeting strategy has demonstrated a capacity to enhance T-cell infiltration and immune response while disrupting tumor blood vessels. Ivonescimab's recent success over pembrolizumab in lung cancer trials underscores the promise of PD-1 x VEGF antibodies. NY-500, benefiting from NAYA's FLEX format and AI-optimization, is scheduled to enter monotherapy phase 1/2a clinical trials in early 2026 for hepatocellular carcinoma and other solid tumors.”
0 · Reply